Literature DB >> 28508880

Prostate cancer: 'The prostate' in patients with metastatic prostate cancer: to treat or not to treat?

Fred Saad1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28508880     DOI： 10.1038/nrurol.2017.72

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  7 in total

1.  Local Therapy Improves Survival in Metastatic Prostate Cancer.

Authors:  Sami-Ramzi Leyh-Bannurah; Stéphanie Gazdovich; Lars Budäus; Emanuele Zaffuto; Alberto Briganti; Firas Abdollah; Francesco Montorsi; Jonas Schiffmann; Mani Menon; Shahrokh F Shariat; Margit Fisch; Felix Chun; Thomas Steuber; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2017-04-03       Impact factor: 20.096

2.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Authors:  Laurence Klotz; Danny Vesprini; Perakaa Sethukavalan; Vibhuti Jethava; Liying Zhang; Suneil Jain; Toshihiro Yamamoto; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

3.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Roger Kockelbergh; Howard Kynaston; Alan Paul; Philip Powell; Stephen Prescott; Derek J Rosario; Edward Rowe; David E Neal
Journal:  N Engl J Med       Date:  2016-09-14       Impact factor: 91.245

4.  Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Authors:  Anders Widmark; Olbjørn Klepp; Arne Solberg; Jan-Erik Damber; Anders Angelsen; Per Fransson; Jo-Asmund Lund; Ilker Tasdemir; Morten Hoyer; Fredrik Wiklund; Sophie D Fosså
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

5.  Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.

Authors:  Sophie D Fosså; Fredrik Wiklund; Olbjørn Klepp; Anders Angelsen; Arne Solberg; Jan-Erik Damber; Morten Hoyer; Anders Widmark
Journal:  Eur Urol       Date:  2016-03-26       Impact factor: 20.096

6.  Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.

Authors:  Malcolm D Mason; Wendy R Parulekar; Matthew R Sydes; Michael Brundage; Peter Kirkbride; Mary Gospodarowicz; Richard Cowan; Edmund C Kostashuk; John Anderson; Gregory Swanson; Mahesh K B Parmar; Charles Hayter; Gordana Jovic; Andrea Hiltz; John Hetherington; Jinka Sathya; James B P Barber; Michael McKenzie; Salah El-Sharkawi; Luis Souhami; P D John Hardman; Bingshu E Chen; Padraig Warde
Journal:  J Clin Oncol       Date:  2015-02-17       Impact factor: 44.544

7.  Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.

Authors:  Nicholas D James; Melissa R Spears; Noel W Clarke; David P Dearnaley; Malcolm D Mason; Christopher C Parker; Alastair W S Ritchie; J Martin Russell; Francesca Schiavone; Gerhardt Attard; Johann S de Bono; Alison Birtle; Daniel S Engeler; Tony Elliott; David Matheson; Joe O'Sullivan; Delia Pudney; Narayanan Srihari; Jan Wallace; Jim Barber; Isabel Syndikus; Mahesh K B Parmar; Matthew R Sydes
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.